Celularity (CELU)
US Market

Celularity (CELU) Income Statement


Celularity Income Statement

Last quarter (Q2 2023), Celularity's total revenue was $1.28M, a decrease of -66.15% from the same quarter last year. In Q2, Celularity's net income was $-47.95M. See Celularity’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20
Total Revenue
$ 13.48M$ 17.98M$ 21.34M$ 14.28M
Cost of Revenue
$ 12.62M$ 19.66M$ 9.65M$ 4.93M
Gross Profit
$ -65.80M$ -1.69M$ 11.68M$ 9.35M
Operating Expense
$ -16.88M$ 20.30M$ 161.89M$ 87.44M
Operating Income
$ -48.92M$ -21.99M$ -150.20M$ -78.09M
Net Non Operating Interest Income Expense
$ -5.36M$ -2.67M$ -2.84M$ -1.98M
Other Income Expense
$ 36.87M$ -42.47M$ 52.95M$ -132.86M
Pretax Income
$ -82.74M$ 14.21M$ -100.10M$ -212.93M
Tax Provision
$ -4.00K$ 13.00K$ 20.00K$ -4.70M
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -82.73M$ 14.19M$ -100.12M$ -208.23M
Basic EPS
$ -0.92$ 0.10$ -1.49$ -1.70
Diluted EPS
$ -0.43$ 0.09$ -1.49$ -1.70
Basic Average Shares
$ 614.51M$ 139.91M$ 67.06M$ 122.49M
Diluted Average Shares
$ 632.31M$ 149.83M$ 67.06M$ 122.49M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ -4.26M$ 39.97M$ 171.54M$ 92.37M
Net Income From Continuing And Discontinued Operation
$ -82.73M$ 14.19M$ -100.12M$ -208.23M
Normalized Income
$ -58.52M-$ -154.75M$ -74.29M
Interest Expense
--$ 3.17M$ 2.35M
$ -77.27M$ 14.21M$ -96.93M$ -210.58M
$ -71.46M$ 23.64M$ -88.11M$ -202.41M
Currency in USD

Celularity Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis